- Home
- LOT vs LENZ Comparison
LOT vs LENZ Comparison
Compare LOT & LENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOT
- LENZ
- Stock Information
- Founded
- LOT 1948
- LENZ 2019
- Country
- LOT China
- LENZ United States
- Employees
- LOT N/A
- LENZ N/A
- Industry
- LOT
- LENZ Medicinal Chemicals and Botanical Products
- Sector
- LOT
- LENZ Health Care
- Exchange
- LOT NYSE
- LENZ Nasdaq
- Market Cap
- LOT 956.3M
- LENZ 819.1M
- IPO Year
- LOT N/A
- LENZ 2021
- Fundamental
- Price
- LOT $2.24
- LENZ $29.79
- Analyst Decision
- LOT
- LENZ Strong Buy
- Analyst Count
- LOT 0
- LENZ 5
- Target Price
- LOT N/A
- LENZ $41.80
- AVG Volume (30 Days)
- LOT 70.6K
- LENZ 358.4K
- Earning Date
- LOT 06-25-2025
- LENZ 05-07-2025
- Dividend Yield
- LOT N/A
- LENZ N/A
- EPS Growth
- LOT N/A
- LENZ N/A
- EPS
- LOT N/A
- LENZ N/A
- Revenue
- LOT $844,090,000.00
- LENZ N/A
- Revenue This Year
- LOT $40.53
- LENZ N/A
- Revenue Next Year
- LOT $87.99
- LENZ $544.79
- P/E Ratio
- LOT N/A
- LENZ N/A
- Revenue Growth
- LOT 1.33
- LENZ N/A
- 52 Week Low
- LOT $1.06
- LENZ $16.54
- 52 Week High
- LOT $7.42
- LENZ $38.93
- Technical
- Relative Strength Index (RSI)
- LOT 58.83
- LENZ 55.47
- Support Level
- LOT $2.02
- LENZ $28.45
- Resistance Level
- LOT $2.75
- LENZ $30.80
- Average True Range (ATR)
- LOT 0.14
- LENZ 1.78
- MACD
- LOT 0.01
- LENZ -0.06
- Stochastic Oscillator
- LOT 40.30
- LENZ 58.12
About LOT LOTUS TECHNOLOGY INC
Lotus Technology Inc is a battery electric vehicle (BEV) maker that designs, develops, and sells BEV lifestyle vehicles under the Lotus brand. The Group is also a distributor that sells luxury sports cars under the Lotus brand. It also provides other sales and ancillary services to customers.
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.